the therapeutic and adverse effects of 2 weeks of treatment with high-dose indomethacin ( 150 mg/day ) were compared with those of low-dose indomethacin ( 50 mg/day ) combined with paracetamol ( 4 g/day ) in a double-blind , double-dummy , cross-over study in 17 patients with active rheumatoid arthritis .
C0021246
indomethacin
C0003873
rheumatoid arthritis